|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Chloropentafluoroethane | CAS 76-15-3 | ||
| CClF2CF3 | RTECS KH7877500 | ||
|
Synonyms & Trade Names Fluorocarbon-115, Freon® 115, Genetron® 115, Halocarbon 115, Monochloropentafluoroethane |
DOT ID & Guide 1020 126 |
||
|
Exposure Limits |
NIOSH REL: TWA 1000 ppm (6320 mg/m3) | ||
| OSHA PEL�: none | |||
| IDLH N.D. | Conversion 1 ppm = 6.32 mg/m3 | ||
|
Physical Description Colorless gas with a slight, ethereal odor. [Note: Shipped as a liquefied compressed gas.] |
|||
|
MW: 154.5 |
BP: -38°F |
FRZ: -223°F |
Sol(77°F): 0.006% |
|
VP(70°F): 7.9 atm |
IP: 12.96 eV |
RGasD: 5.55 |
|
|
Fl.P: NA |
UEL: NA |
LEL: NA |
|
| Nonflammable Gas | |||
|
Incompatibilities & Reactivities Alkalis, alkaline earth metals (e.g., aluminum powder, sodium, potassium, zinc) |
|||
|
Measurement Methods None available |
|
Personal Protection & Sanitation Skin: Frostbite Eyes: Frostbite Wash skin: No recommendation Remove: No recommendation Change: No recommendation Provide: Frostbite |
First Aid (See procedures) Eye: Frostbite Skin: Frostbite Breathing: Respiratory support |
| Respirator Recommendations To be added later | |
| Exposure Routes inhalation, skin and/or eye contact (liquid) | |
| Symptoms Dyspnea (breathing difficulty); dizziness, incoordination, narcosis; nausea, vomiting; heart palpitations, cardiac arrhythmias, asphyxia; liquid: frostbite, dermatitis | |
|
Target Organs
Skin, central nervous system, cardiovascular system |
|
| See also: INTRODUCTION |